Inventor · disambiguated record
Sherie L. Morrison
Also filed as: MORRISON SHERIE · MORRISON SHERIE L · MORRISON SHERIE LEAVER
25 granted patents·20 pending applications·3,106 citations·filing 1993–2023
97Inventor score
Top patents by PatentIndex Score
45 records- 0198US5807715AMethods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulinUNIV LELAND STANFORD JUNIOR·Filed 1994·Granted Sep 15, 1998·1.7k cites·62 claims
- 0297US9803021B2CD138-targeted interferon demonstrates potent apoptotic and anti-tumor activitiesUNIV CALIFORNIA·Filed 2013·Granted Oct 31, 2017·23 cites·18 claims
- 0397US9139634B2Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activitiesMORRISON SHERIE L·Filed 2008·Granted Sep 22, 2015·79 cites·16 claims
- 0495US8258263B2Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activitiesMORRISON SHERIE L·Filed 2009·Granted Sep 4, 2012·39 cites·28 claims
- 0594US6218149B1Antibodies having modified carbohydrate content and methods of preparation and useTRUSTEES OF COLUMBUS UNIVERSIT·Filed 1995·Granted Apr 17, 2001·194 cites·12 claims
- 0694US5977307ATransferrin receptor specific ligand-neuropharmaceutical agent fusion proteinsALKERMES INC·Filed 1995·Granted Nov 2, 1999·395 cites·6 claims
- 0794US5672683ATransferrin neuropharmaceutical agent fusion proteinALKERMES INC·Filed 1993·Granted Sep 30, 1997·280 cites·11 claims
- 0893US8563692B2Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activitiesMORRISON SHERIE L·Filed 2011·Granted Oct 22, 2013·12 cites·19 claims
- 0991US11136353B2Fusion protein composition(s) comprising masked type I interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereofQWIXEL THERAPEUTICS LLC·Filed 2020·Granted Oct 5, 2021·3 cites·31 claims
- 1091US10822427B2Anti-CSPG4 fusions with interferon for the treatment of malignancyUNIV CALIFORNIA·Filed 2018·Granted Nov 3, 2020·7 cites·21 claims
- 1191US6284536B1Modified immunoglobin molecules and methods for use thereofUNIV CALIFORNIA·Filed 1999·Granted Sep 4, 2001·203 cites·31 claims
- 1290US10975158B2CD138-targeted interferon demonstrates potent apoptotic and anti-tumor activitiesUNIV CALIFORNIA·Filed 2017·Granted Apr 13, 2021·3 cites·13 claims
- 1389US12162958B2Fusion protein composition(s) comprising masked type i interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereofQWIXEL THERAPEUTICS LLC·Filed 2023·Granted Dec 10, 2024·1 cites·29 claims
- 1489US10182984B2Targeted interferons demonstrate potent apoptotic and anti-tumor activitiesUNIV CALIFORNIA·Filed 2016·Granted Jan 22, 2019·3 cites·17 claims
- 1588US9534033B2Targeted interferons demonstrating potent apoptotic and anti-tumor activitiesUNIV CALIFORNIA·Filed 2013·Granted Jan 3, 2017·5 cites·11 claims
- 1684US10093745B2Anti-CSPG4 fusions with interferon for the treatment of malignancyUNIV CALIFORNIA·Filed 2014·Granted Oct 9, 2018·5 cites·11 claims
- 1781US7736652B2Antibody fusion proteins: effective adjuvants of protein vaccinationUNIV CALIFORNIA·Filed 2002·Granted Jun 15, 2010·18 cites·19 claims
- 1877US6861572B1Production of proteins in eggsORIGEN THERAPEUTICS INC·Filed 1998·Granted Mar 1, 2005·53 cites·10 claims
- 1974US6300104B1Secretory immunoglobulin produced by single cells and methods for making and using sameUNIV CALIFORNIA·Filed 1998·Granted Oct 9, 2001·50 cites·19 claims
- 2072US11795198B2Fusion protein composition(s) comprising masked type I interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereofQWIXEL THERAPEUTICS LLC·Filed 2021·Granted Oct 24, 2023·0 cites·27 claims
- 2160US2005114916A1Production of proteins in eggsFiled 2004·Application pending·0 cites
- 2260US2010192241A1Production of Proteins in EggsETCHES ROBERT J·Filed 2009·Application pending·0 cites
- 2357US9611313B2Antibody-endostatin fusion protein and its variantsUNIV MIAMI·Filed 2014·Granted Apr 4, 2017·0 cites·10 claims
- 2457US2009083872A1Production of Proteins in EggsETCHES ROBERT J·Filed 2008·Application pending·0 cites
- 2555US6043345AIgE isoforms and methods of useUNIV CALIFORNIA·Filed 1996·Granted Mar 28, 2000·15 cites·4 claims
- 2652US2005085419A1Anti-growth factor receptor avidin fusion proteins as universal vectors for drug deliveryUNIV CALIFORNIA·Filed 2004·Application pending·0 cites
- 2751US2008213890A1Antibody-avidin fusion proteins as cytotoxic drugsUNIV CALIFORNIA·Filed 2008·Application pending·0 cites
- 2851US2002028486A1Antibodies having modified carbohydrate content and methods of preparation and useUNIV COLUMBIA·Filed 2001·Application pending·0 cites
- 2951US2017145110A1Antibody-endostatin fusion protein and its variantsUNIV MIAMI·Filed 2016·Application pending·0 cites
- 3049US12415843B2Antibody-interferon fusion proteins for enhancing adoptive T cell therapies for the treatment of cancerUNIV CALIFORNIA·Filed 2019·Granted Sep 16, 2025·0 cites·13 claims
- 3149US2011296541A1Production of proteins in eggsETCHES ROBERT J·Filed 2011·Application pending·0 cites
- 3249US2022177598A1Targeted delivery of ifn gamma using antibody fusion proteinsUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 3349US2005008649A1Chimeric molecules and methods of useUNIV MIAMI·Filed 2004·Application pending·0 cites
- 3449US2002127645A1Secretory immunoglobulin produced by single cells and methods for making and using sameUNIV CALIFORNIA·Filed 2001·Application pending·0 cites
- 3547US2007003514A1Mono-and bi-functional antibody conjugates as effective adjuvants of protein vaccinationUNIV CALIFORNIA·Filed 2005·Application pending·0 cites
- 3644US7238784B2Rh antibodyUNIV CALIFORNIA·Filed 2002·Granted Jul 3, 2007·0 cites·16 claims
- 3744US2003133938A1Antibody-avidin fusion proteins as cytotoxic drugsFiled 2002·Application pending·0 cites
- 3844US2011038865A1Antibody- endostatin fusion protein and its variantsUNIV MIAMI·Filed 2008·Application pending·0 cites
- 3941US2004052814A1Fusion proteins for targeted delivery of antimicrobial peptidesFiled 2001·Application pending·0 cites
- 4039US6475749B1Rh hybrid antibodyUNIV CALIFORNIA·Filed 1999·Granted Nov 5, 2002·8 cites·2 claims
- 4138US2003143234A1Anti-microbial targeting chimeric pharmaceuticalFiled 2002·Application pending·0 cites
- 4237US2002068066A1Method for the treatment and prevention of dental cariesFiled 2001·Application pending·0 cites
- 4336US2006029597A1IgA antibody protein as a cytotoxic drugCHIMERIC TECHNOLOGIES·Filed 2005·Application pending·0 cites
- 4434US2011165122A1Method for targeted and sustained antiviral therapyUNIV CALIFORNIA·Filed 2010·Application pending·0 cites
- 4523US2003171551A1Chimeric antibody fusion proteins for the recruitment and stimulation of an antitumor immune responseFiled 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sherie L. Morrison files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →